MYNZ
Mainz Biomed·NASDAQ
--
--(--)
--
--(--)
3.75 / 10
Netural
Fund flow evaluation: 7.49/10 reflecting robust fund flow characteristics. Constructive no significant trends trends face headwinds from adverse overall, block, Small, Medium, Large, and Extra-large developments, indicating positive money flow direction. The analyst community expresses overwhelmingly bullish analyst consensus with strong conviction. Ratings composition: Strong Buy(100.0%) representing 1 analyst views, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-02-14
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for MYNZ?
- MYNZ holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.75/10 (Netural).
